BioCryst Pharmaceuticals Inc (BCRX)
7.485
+0.18
(+2.53%)
USD |
NASDAQ |
Nov 21, 16:00
7.485
0.00 (0.00%)
After-Hours: 20:00
BioCryst Pharmaceuticals Profit Margin (Quarterly): -11.99% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -11.99% |
| June 30, 2024 | -11.59% |
| March 31, 2024 | -38.14% |
| December 31, 2023 | -66.09% |
| September 30, 2023 | -41.67% |
| June 30, 2023 | -91.31% |
| March 31, 2023 | -77.54% |
| December 31, 2022 | -89.94% |
| September 30, 2022 | -56.08% |
| June 30, 2022 | -89.82% |
| March 31, 2022 | -148.6% |
| December 31, 2021 | -37.70% |
| September 30, 2021 | -143.4% |
| June 30, 2021 | -86.47% |
| March 31, 2021 | -337.3% |
| December 31, 2020 | -1.51K% |
| September 30, 2020 | -755.7% |
| June 30, 2020 | -1.34K% |
| March 31, 2020 | -779.6% |
| December 31, 2019 | -6.60% |
| September 30, 2019 | -2.12K% |
| June 30, 2019 | -2.60K% |
| March 31, 2019 | -527.5% |
| December 31, 2018 | -1.01K% |
| September 30, 2018 | -2.04K% |
| Date | Value |
|---|---|
| June 30, 2018 | -147.6% |
| March 31, 2018 | -648.3% |
| December 31, 2017 | -502.4% |
| September 30, 2017 | -172.8% |
| June 30, 2017 | -544.9% |
| March 31, 2017 | -150.7% |
| December 31, 2016 | -50.13% |
| September 30, 2016 | -148.5% |
| June 30, 2016 | -340.1% |
| March 31, 2016 | -473.7% |
| December 31, 2015 | -394.1% |
| September 30, 2015 | -133.1% |
| June 30, 2015 | 18.97% |
| March 31, 2015 | -222.2% |
| December 31, 2014 | -214.3% |
| September 30, 2014 | -269.6% |
| June 30, 2014 | -999.2% |
| March 31, 2014 | -293.1% |
| December 31, 2013 | -51.38% |
| September 30, 2013 | -334.9% |
| June 30, 2013 | -1.48K% |
| March 31, 2013 | -126.8% |
| December 31, 2012 | -269.5% |
| September 30, 2012 | -168.4% |
| June 30, 2012 | -291.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.51K%
Minimum
Dec 2020
-6.60%
Maximum
Dec 2019
-286.0%
Average
-88.14%
Median
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -10.57K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 18.02% |
| Electromed Inc | 10.05% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -25.05% |
| Return on Invested Capital | -34.87% |
| Gross Profit Margin (Quarterly) | 97.24% |
| Operating Margin (Quarterly) | 6.57% |
| Return on Net Operating Assets | -133.5% |